Abstract C017: Preclinical evaluation of EZH2 inhibitor tazemetostat-based combination therapies to treat lymphoma and solid tumors
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Huijing Yu, Jia Hu, Shiming Fan, Juntao Yu, Qi Ding, Ying Yu, Tingwen Li, Xiaoya Wang, Longxian Jiao, Dongxia Shi, Min Cheng, Linfang Wang, Yongxin Ren, Weiguo Su
Institution: HUTCHMED (China) Limited (China)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7093358798
Cites:
Cited by:
Related to: